Enliven Therapeutics, Inc.
Industry: Life Sciences ・ $ELVN on Nasdaq
Insider Sale
+$51,383
-100%
Shares
Shares Volume: 3,250 Shares
Average Share Price: $15.81
INSIDER
Hohl Benjamin
CHIEF FINANCIAL OFFICER (Officer)
reported on Jan 31 2024
traded on Jan 29 2024
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 0 |
| PURCHASES/SALES 1Y | 0 / 3 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $82,261.27 |
| INSIDER PREVIOUS TRADES |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 3 |
| PURCHASES/SALES 1Y | 0 / 25 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $483,614.75 |
| COMPANY PREVIOUS TRADES |